198 related articles for article (PubMed ID: 30418544)
1. Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure.
Müller OJ; Heckmann MB; Ding L; Rapti K; Rangrez AY; Gerken T; Christiansen N; Rennefahrt UEE; Witt H; González Maldonado S; Ternes P; Schwab DM; Ruf T; Hille S; Remes A; Jungmann A; Weis TM; Kreußer JS; Gröne HJ; Backs J; Schatz P; Katus HA; Frey N
Cardiovasc Res; 2019 Jul; 115(8):1296-1305. PubMed ID: 30418544
[TBL] [Abstract][Full Text] [Related]
2. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.
Chen QQ; Wang FX; Cai YY; Zhang YK; Fang JK; Qi LW; Zhang L; Huang FQ
J Ethnopharmacol; 2021 Apr; 270():113646. PubMed ID: 33264659
[TBL] [Abstract][Full Text] [Related]
4. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.
Kolwicz SC; Olson DP; Marney LC; Garcia-Menendez L; Synovec RE; Tian R
Circ Res; 2012 Aug; 111(6):728-38. PubMed ID: 22730442
[TBL] [Abstract][Full Text] [Related]
6. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
7. Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure.
Kärkkäinen O; Tuomainen T; Mutikainen M; Lehtonen M; Ruas JL; Hanhineva K; Tavi P
Cardiovasc Res; 2019 Jan; 115(1):107-118. PubMed ID: 29931052
[TBL] [Abstract][Full Text] [Related]
8. Heart spotting.
el Azzouzi H; De Windt LJ
Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
[TBL] [Abstract][Full Text] [Related]
9. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
10. Expression of the organic cation/carnitine transporter family (Octn1,-2 and-3) in mdx muscle and heart: Implications for early carnitine therapy in Duchenne muscular dystrophy to improve cellular carnitine homeostasis.
Lamhonwah AM; Tein I
Clin Chim Acta; 2020 Jun; 505():92-97. PubMed ID: 32070725
[TBL] [Abstract][Full Text] [Related]
11. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
[TBL] [Abstract][Full Text] [Related]
12. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Obinata H; Yamaguchi A; Hanaoka H; Hishiki T; Hayakawa N; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Sci Rep; 2018 Aug; 8(1):12035. PubMed ID: 30104639
[TBL] [Abstract][Full Text] [Related]
13. Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.
Byrne NJ; Levasseur J; Sung MM; Masson G; Boisvenue J; Young ME; Dyck JR
Cardiovasc Res; 2016 May; 110(2):249-57. PubMed ID: 26968698
[TBL] [Abstract][Full Text] [Related]
14. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
Abdurrachim D; Nabben M; Hoerr V; Kuhlmann MT; Bovenkamp P; Ciapaite J; Geraets IME; Coumans W; Luiken JJFP; Glatz JFC; Schäfers M; Nicolay K; Faber C; Hermann S; Prompers JJ
Cardiovasc Res; 2017 Aug; 113(10):1148-1160. PubMed ID: 28549111
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.
Bernardo BC; Weeks KL; Pongsukwechkul T; Gao X; Kiriazis H; Cemerlang N; Boey EJH; Tham YK; Johnson CJ; Qian H; Du XJ; Gregorevic P; McMullen JR
Clin Sci (Lond); 2018 Feb; 132(3):381-397. PubMed ID: 29358507
[TBL] [Abstract][Full Text] [Related]
16. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
17. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.
Ruiz M; Labarthe F; Fortier A; Bouchard B; Thompson Legault J; Bolduc V; Rigal O; Chen J; Ducharme A; Crawford PA; Tardif JC; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H768-H781. PubMed ID: 28710072
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure.
Thai PN; Daugherty DJ; Frederich BJ; Lu X; Deng W; Bers DM; Dedkova EN; Schaefer S
Sci Rep; 2018 Nov; 8(1):16213. PubMed ID: 30385779
[TBL] [Abstract][Full Text] [Related]
19. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
20. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
